283 related articles for article (PubMed ID: 24030499)
1. Innate immune interleukin-1 receptor-associated kinase 4 exacerbates viral myocarditis by reducing CCR5(+) CD11b(+) monocyte migration and impairing interferon production.
Valaperti A; Nishii M; Liu Y; Naito K; Chan M; Zhang L; Skurk C; Schultheiss HP; Wells GA; Eriksson U; Liu PP
Circulation; 2013 Oct; 128(14):1542-54. PubMed ID: 24030499
[TBL] [Abstract][Full Text] [Related]
2. The adapter protein c-Cbl-associated protein (CAP) protects from acute CVB3-mediated myocarditis through stabilization of type I interferon production and reduced cytotoxicity.
Valaperti A; Nishii M; Liu Y; Yang H; Naito K; Liu PP; Eriksson U
Basic Res Cardiol; 2014 May; 109(3):411. PubMed ID: 24763933
[TBL] [Abstract][Full Text] [Related]
3. CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis.
Yuan J; Liu Z; Lim T; Zhang H; He J; Walker E; Shier C; Wang Y; Su Y; Sall A; McManus B; Yang D
Circ Res; 2009 Mar; 104(5):628-38. PubMed ID: 19168435
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin promotes coxsackievirus B3 myocarditis by suppression of acute anti-viral immune responses.
Jenke A; Holzhauser L; Löbel M; Savvatis K; Wilk S; Weithäuser A; Pinkert S; Tschöpe C; Klingel K; Poller W; Scheibenbogen C; Schultheiss HP; Skurk C
Basic Res Cardiol; 2014 May; 109(3):408. PubMed ID: 24691762
[TBL] [Abstract][Full Text] [Related]
5. Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after Coxsackievirus infection.
Hühn MH; McCartney SA; Lind K; Svedin E; Colonna M; Flodström-Tullberg M
Virology; 2010 May; 401(1):42-8. PubMed ID: 20206372
[TBL] [Abstract][Full Text] [Related]
6. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.
Weithauser A; Bobbert P; Antoniak S; Böhm A; Rauch BH; Klingel K; Savvatis K; Kroemer HK; Tschope C; Stroux A; Zeichhardt H; Poller W; Mackman N; Schultheiss HP; Rauch U
J Am Coll Cardiol; 2013 Nov; 62(19):1737-45. PubMed ID: 23871888
[TBL] [Abstract][Full Text] [Related]
7. Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis.
Li M; Yan K; Wei L; Yang J; Lu C; Xiong F; Zheng C; Xu W
Antiviral Res; 2015 Nov; 123():50-61. PubMed ID: 26343012
[TBL] [Abstract][Full Text] [Related]
8. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart.
Fairweather D; Frisancho-Kiss S; Yusung SA; Barrett MA; Davis SE; Steele RA; Gatewood SJ; Rose NR
J Immunol; 2005 Jan; 174(1):261-9. PubMed ID: 15611248
[TBL] [Abstract][Full Text] [Related]
9. Protective role for interferon-beta in coxsackievirus B3 infection.
Deonarain R; Cerullo D; Fuse K; Liu PP; Fish EN
Circulation; 2004 Dec; 110(23):3540-3. PubMed ID: 15249500
[TBL] [Abstract][Full Text] [Related]
10. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production.
Fuse K; Chan G; Liu Y; Gudgeon P; Husain M; Chen M; Yeh WC; Akira S; Liu PP
Circulation; 2005 Oct; 112(15):2276-85. PubMed ID: 16216974
[TBL] [Abstract][Full Text] [Related]
11. In vivo ablation of type I interferon receptor from cardiomyocytes delays coxsackieviral clearance and accelerates myocardial disease.
Althof N; Harkins S; Kemball CC; Flynn CT; Alirezaei M; Whitton JL
J Virol; 2014 May; 88(9):5087-99. PubMed ID: 24574394
[TBL] [Abstract][Full Text] [Related]
12. Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis.
Ruppert V; Meyer T; Pankuweit S; Jonsdottir T; Maisch B
Cardiovasc Pathol; 2008; 17(2):81-92. PubMed ID: 18329552
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor beta-coxsackie-adenovirus receptor pathway.
Shi Y; Fukuoka M; Li G; Liu Y; Chen M; Konviser M; Chen X; Opavsky MA; Liu PP
Circulation; 2010 Jun; 121(24):2624-34. PubMed ID: 20530002
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA profiling identifies microRNA-155 as an adverse mediator of cardiac injury and dysfunction during acute viral myocarditis.
Corsten MF; Papageorgiou A; Verhesen W; Carai P; Lindow M; Obad S; Summer G; Coort SL; Hazebroek M; van Leeuwen R; Gijbels MJ; Wijnands E; Biessen EA; De Winther MP; Stassen FR; Carmeliet P; Kauppinen S; Schroen B; Heymans S
Circ Res; 2012 Aug; 111(4):415-25. PubMed ID: 22715471
[TBL] [Abstract][Full Text] [Related]
15. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.
Liu H; Li M; Song Y; Xu W
Front Immunol; 2018; 9():2479. PubMed ID: 30410495
[TBL] [Abstract][Full Text] [Related]
16. Silencing the CSF-1 Axis Using Nanoparticle Encapsulated siRNA Mitigates Viral and Autoimmune Myocarditis.
Meyer IS; Goetzke CC; Kespohl M; Sauter M; Heuser A; Eckstein V; Vornlocher HP; Anderson DG; Haas J; Meder B; Katus HA; Klingel K; Beling A; Leuschner F
Front Immunol; 2018; 9():2303. PubMed ID: 30349538
[TBL] [Abstract][Full Text] [Related]
17. Sex differences in coxsackievirus B3-induced myocarditis: IL-12Rbeta1 signaling and IFN-gamma increase inflammation in males independent from STAT4.
Frisancho-Kiss S; Nyland JF; Davis SE; Frisancho JA; Barrett MA; Rose NR; Fairweather D
Brain Res; 2006 Dec; 1126(1):139-47. PubMed ID: 16949558
[TBL] [Abstract][Full Text] [Related]
18. Lack of IL-6 during coxsackievirus infection heightens the early immune response resulting in increased severity of chronic autoimmune myocarditis.
Poffenberger MC; Straka N; El Warry N; Fang D; Shanina I; Horwitz MS
PLoS One; 2009 Jul; 4(7):e6207. PubMed ID: 19587788
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation by interleukin-4 suppresses matrix metalloproteinases and improves cardiac function in murine myocarditis.
Li J; Leschka S; Rutschow S; Schwimmbeck PL; Husmann L; Noutsias M; Westermann D; Poller W; Zeichhardt H; Klingel K; Tschope C; Schultheiss HP; Pauschinger M
Eur J Pharmacol; 2007 Jan; 554(1):60-8. PubMed ID: 17113076
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis.
Horwitz MS; La Cava A; Fine C; Rodriguez E; Ilic A; Sarvetnick N
Nat Med; 2000 Jun; 6(6):693-7. PubMed ID: 10835688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
